Prenatal and New-born Genetic Testing Market Size, Share, Growth Analysis, By Technology, 2016 - 2027 (USD Million)(Screening, Non-invasive (NIPT)), By Disease, 2016 - 2027 (USD Million)(Down’s Syndrome, Phenylketonuria), By End-use, 2016 - 2027 (USD Million)(Hospital, Maternity and Specialty Clinics) - Industry Forecast 2024-2031

Prenatal and New-born Genetic Testing Market Competitive Landscape

To understand the competitive landscape, we are analyzing key Prenatal and New-born Genetic Testing Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Prenatal and New-born Genetic Testing Market.

To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.

Key Players Covered in the Report:

• Ariosa Diagnostics (Roche)
• Berry Genomics
• BGI
• Biorad
• Illumina
• Laboratory Corporation of America
• Natera
• Qiagen
• Sequenom
• Trivitron Healthcare
• Verinata Health.